MOESM1 of SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARδ signalling-mediated alternative activation of macrophages

Additional file 1: Table S1. Clinicopathological Characteristics of Patients with Hepatocellular Carcinoma (n=90).